Author Page for Jeffrey Cummings

A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer's Disease with BAN2401, an Anti-Aβ Protofibril Antibody

Number of pages: 40 Posted: 29 Sep 2020

Chad Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert YK Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama, Larisa Reyderman, Donald A. Berry, Scott Berry, Robert Gordon, Lynn D. Kramer and Jeffrey Cummings

Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai Ltd., BioArctic AB, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Eisai, Inc. - Eisai, Inc. - United States, Berry Consultants, LLC, Berry Consultants, LLC, Eisai Ltd., Eisai, Inc. - Eisai, Inc. - United States and University of Nevada, Las Vegas - Chambers-Grundy Center for Transformative Neuroscience

Downloads 99 (585,885)

Abstract:

2.

The Effects of Rasagiline on Glucose Metabolism and Cognition and Their Relationship to Tau Burden in a Double-Blind, Placebo-Controlled Phase Ii Clinical Trial of Participants with Alzheimer's Dementia

Number of pages: 99 Posted: 16 Mar 2020

Dawn Matthews, Aaron Ritter, Ronald G. Thomas, Randolph D. Andrews, Ana S. Lukic, Carolyn Revta, Babak Tousi, James B. Leverenz, Howard Fillit, Kate Zhong, Howard H. Feldman and Jeffrey Cummings

ADM Diagnostics, Inc., Cleveland Clinic - Lou Ruvo Center for Brain Health, University of California, San Diego (UCSD) - Department of Family Medicine and Public Health, ADM Diagnostics, Inc., ADM Diagnostics, Inc., University of California, San Diego (UCSD) - Alzheimer’s Disease Cooperative Study, Cleveland Clinic - Neurological Institute, Cleveland Clinic - Lou Ruvo Center for Brain Health, Alzheimer’s Drug Discovery Foundation, CNS Innovations, LLC, University of California, San Diego (UCSD) - Alzheimer’s Disease Cooperative Study and University of Nevada, Las Vegas - Chambers-Grundy Center for Transformative Neuroscience

Downloads 57 (802,933)

Abstract:

3.

Single-Microglia Transcriptomic Transition Network-Based Prediction and Real-World Patient Data Validation Identifies Ketorolac as a Repurposable Drug for Alzheimer's Disease

Number of pages: 64 Posted: 28 Dec 2023

Jielin Xu, Michael Danziger, Zhenxing Wu, Chengxi Zang, Yadi Zhou, Yuan Hou, Ehud Karavani, Yishai Shimoni, Andrew A. Pieper, James B. Leverenz, Jeffrey Cummings, Jianying Hu, Fei Wang, Michal Rosen-Zvi and Feixiong Cheng

Cleveland Clinic, IBM Research, Israel, Cornell University - Weill Cornell Medicine, Cornell University - Weill Cornell Medicine, Cleveland Clinic - Genomic Medicine Institute, Cleveland Clinic, IBM Research, Israel, IBM Research, Israel, Case Western Reserve University, Cleveland Clinic - Lou Ruvo Center for Brain Health, University of Nevada, Las Vegas - Chambers-Grundy Center for Transformative Neuroscience, IBM Research, Cornell University - Weill Cornell Medicine, IBM Research, Israel and Cleveland Clinic - Genomic Medicine Institute

Downloads 36 (984,153)

Citation 7

Jeffrey Cummings

University of Nevada, Las Vegas - Chambers-Grundy Center for Transformative Neuroscience

Cleveland Clinic - Lou Ruvo Center for Brain Health

3

192

7

Scholarly Papers (3)

A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer's Disease with BAN2401, an Anti-Aβ Protofibril Antibody

Abstract:

The Effects of Rasagiline on Glucose Metabolism and Cognition and Their Relationship to Tau Burden in a Double-Blind, Placebo-Controlled Phase Ii Clinical Trial of Participants with Alzheimer's Dementia

Abstract:

Single-Microglia Transcriptomic Transition Network-Based Prediction and Real-World Patient Data Validation Identifies Ketorolac as a Repurposable Drug for Alzheimer's Disease

Abstract: